子宫腺肌症合并不孕患者中宫腔镜的作用:让隐匿病变显现
视频病例系列描述3例多次体外受精失败且超声见子宫腺肌症(子宫肌层囊肿)的不孕患者,经促性腺激素释放激素激动剂3.75 mg至少2个月、必要时加用来曲唑2.5 mg/日达到低雌激素后,对持续存在的囊肿行超声引导下宫腔镜治疗,术后1个月胚胎移植,患者均获得妊娠。
要点
- 子宫肌层交界区囊性腺肌症病变经GnRH激动剂抑制治疗后可持续存在。
- GnRH激动剂未达满意低雌激素时,来曲唑2.5 mg/日是可用的添加治疗。
- 超声示药物难治性病变者,宫腔镜治疗可改善生殖结局。
核心结论
- 对于药物治疗后持续存在的子宫肌层交界区囊性腺肌症病变,宫腔镜治疗可能有用,作者提出药物与手术联合的治疗策略。
- 进一步研究需要验证所提出的方案。
研究设计与样本
- 视频病例系列,展示不孕并多次体外受精失败患者中子宫肌层交界区囊性腺肌症病变的宫腔镜治疗。
- 从大学医院生育中心大量不孕并子宫肌层交界区囊性腺肌症接受体外受精的患者中选取3例。
主要发现
- 并非所有子宫肌层交界区囊性腺肌症病变在GnRH激动剂抑制治疗后消退。
- GnRH激动剂未达满意低雌激素时,来曲唑是有效的添加治疗。
- 超声示难治性病变者接受宫腔镜治疗,联合药物与手术治疗的患者获得妊娠。
关键数值与推荐
- GnRH激动剂3.75 mg用于至少2个月以达到低雌激素(血清雌二醇<40 pg/mL)和病变缩小。
- 若未达到低雌激素,加用来曲唑2.5 mg/日。
- 超声示病变持续(即囊肿对药物治疗难治)者行宫腔镜,并在超声引导下治疗所见病变。
- 宫腔镜后1个月进行胚胎移植。
临床怎么用
- 作者建议对药物治疗后持续存在的子宫肌层交界区囊性腺肌症病变行宫腔镜治疗,并提出药物与手术联合的治疗策略。
局限性
- 进一步研究需要验证所提出的方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe how hysteroscopic treatment of adenomyotic cystic lesions of the inner myometrium (IM), persisting after pharmacologic treatment, can improve reproductive outcomes in patients with multiple in vitro fertilization (IVF) failures. DESIGN: Video case series demonstrating the infertility workup and the hysteroscopic treatment of adenomyotic cystic lesions of the IM in patients with infertility with multiple IVF failures. SUBJECTS: Out of a large experience of patients with infertility and IM/junctional zone cystic adenomyosis undergoing IVF in the Fertility Center of our university hospital, we selected 3 patients for this case series. All 3 patients had a personal history of repeated implantation failure and sonographic evidence of adenomyosis (myometrial cysts). EXPOSURE: Patients underwent initial pelvic 2-dimensional and 3-dimensional sonographic assessment, according to the protocol of the Fertility Center of our university hospital. All patients were diagnosed with adenomyosis (myometrial cysts). The patients were treated with gonadotropin-releasing hormone (GnRH) agonists 3.75 mg for at least 2 months to achieve hypoestrogenism (serum estradiol level, <40 pg/mL) and lesions shrinkage. If hypoestrogenism was not achieved, letrozole 2.5 mg/daily was added. In case of lesions persistence at ultrasound (i.e., cysts refractory to pharmacologic treatment), patients underwent hysteroscopy, and identified lesions were treated under sonographic guidance. One month after hysteroscopy, embryo transfer was performed. MAIN OUTCOME MEASURES: Achievement of pregnancy in women with infertility with multiple IVF failures and adenomyotic cystic lesions, undergoing medical and surgical treatment for adenomyosis. RESULTS: Not all cystic adenomyotic lesions of the IM regress after hypothalamic-pituitary-ovarian axis-suppressive treatment (GnRH agonist). When GnRH agonist treatment is not sufficient to achieve satisfactory hypoestrogenism, letrozole is an effective add-on. In cases of refractory lesions at ultrasound, hysteroscopic treatment can improve reproductive outcomes. Patients undergoing combined hysteroscopic and medical treatment achieved pregnancy. CONCLUSION: The optimal management of adenomyotic cystic lesions in patients undergoing IVF is debated. This case series suggests the usefulness of hysteroscopic treatment of adenomyotic cystic lesions persistent after medical therapy, in patients with infertility with a personal history of multiple IVF failures. We propose a combined medical and surgical treatment strategy. Further studies are required to validate the proposed protocol.
引用
- Di Spiezio Sardo A, Iorio GG, Guerra S, et al. The role of hysteroscopy in patients with adenomyosis and infertility: bringing out the submerged. Fertil Steril. 2025. PMID: 39924098. doi:10.1016/j.fertnstert.2025.02.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。